Sean D. Sullivan
Professor of Pharmacy, Public Health and Medicine
University of Washington
Seattle, WA, USA
email: [email protected]
Author's reply
Anthony P. Morreale
Chief, Pharmacy Service VA San Diego Healthcare System
Director, Pharmacoeconomics Residency Program
Email: [email protected]
References
- Morreale A, Plowman B, DeLattre M, et al. Clinical and economic comparison of epoetin alfa and darbepoetin alfa. Curr Med Res and Opin 2004;20(3):381–95
- Glaspy JA, Jadeja JS, Justice G, Kessler J, Richards D, Schwartzberg L, et al. Darbepoetin alfa given every 1 or 2 weeks alleviates anemia associated with cancer chhemotherapy. Br J Cancer 2002;87:268–76
- Vadhan-Raj S, Mirtsching B, Charu V, et al. Assessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks. J Support Oncol 2003;1:131–8